Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
Parving HH; Brenner BM; McMurray JJ; de Zeeuw D; Haffner SM; Solomon SD; Chaturvedi N; Persson F; Desai AS; Nicolaides M; Richard A; Xiang Z; Brunel P; Pfeffer MA; The New England Journal Of Medicine, 2012, vol. 367, issue 23, p 2204, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation